first generation glp 1 GLP-1 receptor agonism: a transformative approach for managing type-2 diabetes and obesity GLP-1: Transforming weight loss and

GLP-1 drugs like Ozempic and Wegovy are groundbreaking treatments for type 2 diabetes and obesity

Weight regain after stopping semaglutide or tirzepatide is a real concern

Patients in Sandy Springs and Atlanta who suffered severe gastrointestinal injuries, stomach paralysis, or vision loss may have claims not only against drug manufacturers but also against prescribing physicians who failed to follow safe prescribing practices or warn patients about significant risks

Our topic modeling pipeline identified a total of 168 discussion topics (Supplementary Data 1), with most discussions focusing on individual experiences with GLP-1 RA for weight loss with respect to medication efficacy, comparison to other treatments, impact on appetite, and side effects

That's completely fine, if you're hitting your protein targets (100-120g daily) and feeling energized